CSIMarket
 


Rock Creek Pharmaceuticals, Inc.  (RCPI)
Other Ticker:  
 

Rock Creek Pharmaceuticals's Quick Ratio

RCPI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Rock Creek Pharmaceuticals's Cash & cash equivalent grew by 11.97 % in the I Quarter 2016 sequentially, while Current Liabilities decreased, this led to improvement in Rock Creek Pharmaceuticals's Quick Ratio to 0.03, Quick Ratio remained below Rock Creek Pharmaceuticals, Inc. average.

Within Major Pharmaceutical Preparations industry 355 other companies have achieved higher Quick Ratio than Rock Creek Pharmaceuticals in first quarter 2016. While Quick Ratio total ranking has improved so far during the I Quarter 2016 to 4330, from total ranking in the forth quarter 2015 at 5139.

Explain Quick Ratio?
How much Cash & cash equivalents RCPI´s has?
What are RCPI´s Current Liabilities?


RCPI Quick Ratio (Mar 31 2016)
I. Quarter
(Dec 31 2015)
IV. Quarter
(Sep 30 2015)
III. Quarter
(Jun 30 2015)
II. Quarter
(Mar 31 2015)
I. Quarter
Y / Y Current Liabilities Change 51.11 % 14.39 % 2.82 % 2.25 % 180.24 %
Y / Y Cash & cash equivalent Change 506.59 % 24.81 % -94.53 % -20.17 % -99.11 %
Quick Ratio MRQ 0.03 0.02 0.01 0.28 0.01
RCPI's Total Ranking # 4330 # 5139 # 4485 # 5123 # 5126
Seq. Current Liabilities Change -1.62 % 98.51 % 6.4 % -27.28 % -25.53 %
Seq. Cash & cash equivalent Change 11.97 % 237.67 % -95.12 % 3189.01 % -76.96 %



Quick Ratio first quarter 2016 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 356
Healthcare Sector # 722
Overall Market # 4330


Quick Ratio Statistics
High Average Low
1.98 0.3 0.01
(Dec 31 2011)   (Mar 31 2015)




Financial Statements
Rock Creek Pharmaceuticals's Current Liabilities $ 22 Millions Visit RCPI's Balance sheet
Rock Creek Pharmaceuticals's Cash & cash equivalent $ 1 Millions Visit RCPI's Balance sheet
Source of RCPI's Sales Visit RCPI's Sales by Geography


Cumulative Rock Creek Pharmaceuticals's Quick Ratio

RCPI's Quick Ratio for the trailling 12 Months

RCPI Quick Ratio

(Mar 31 2016)
I. Quarter
(Dec 31 2015)
IV. Quarter
(Sep 30 2015)
III. Quarter
(Jun 30 2015)
II. Quarter
(Mar 31 2015)
I. Quarter
Y / Y Current Liabilities TTM Growth 51.11 % 14.39 % 2.82 % 2.25 % 180.24 %
Y / Y Cash & cash equivalent TTM Growth 506.59 % 24.81 % -94.53 % -20.17 % -99.11 %
Quick Ratio TTM 0.06 0.06 0.07 0.11 0.13
Total Ranking TTM # 3526 # 3689 # 3515 # 3554 # 3654
Seq. Current Liabilities TTM Growth -1.62 % 98.51 % 6.4 % -27.28 % -25.53 %
Seq. Cash & cash equivalent TTM Growth 11.97 % 237.67 % -95.12 % 3189.01 % -76.96 %


On the trailing twelve months basis In Spite of the decrease in Current Liabilities in the I Quarter 2016 to $21.83 millions, cumulative Quick Ratio remained unchanged at 0.06 below the Rock Creek Pharmaceuticals, Inc. average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 170 other companies have achieved higher Quick Ratio than Rock Creek Pharmaceuticals. While Quick Ratio overall ranking has improved so far to 3526, from total ranking during the twelve months ending forth quarter 2015 at 3689.

Explain Quick Ratio?
How much Cash & cash equivalents RCPI´s has?
What are RCPI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 171
Healthcare Sector # 438
Within the Market # 3526


trailing twelve months Quick Ratio Statistics
High Average Low
0.37 0.24 0.11
(Dec. 30, 2014)   (June 30. 2015)




Companies with similar Quick Ratio in the quarter ending Mar 31 2016, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2016 MRQ Cash & cash equivalentMar 31 2016 MRQ Current Liabilities
Lumos Pharma Inc   0.07 $ 0.997  Millions$ 15.305  Millions
Aadi Bioscience Inc   0.06 $ 0.013  Millions$ 0.206  Millions
Axim Biotechnologies Inc   0.06 $ 0.171  Millions$ 2.834  Millions
American Bio Medica Corporation  0.06 $ 0.097  Millions$ 1.668  Millions
Nanomix Corp  0.04 $ 0.041  Millions$ 0.912  Millions
Bioadaptives Inc   0.04 $ 0.010  Millions$ 0.280  Millions
Bioxytran Inc   0.03 $ 0.009  Millions$ 0.277  Millions
Cardax Inc   0.03 $ 0.151  Millions$ 4.661  Millions
Rock Creek Pharmaceuticals, Inc.  0.03 $ 0.552  Millions$ 21.834  Millions
Biostax Corp  0.02 $ 0.133  Millions$ 6.340  Millions
Cell Source Inc   0.01 $ 0.099  Millions$ 6.739  Millions
United Cannabis Corp  0.01 $ 0.028  Millions$ 2.279  Millions
Entest Group Inc   0.01 $ 0.008  Millions$ 0.804  Millions
Actavia Life Sciences Inc   0.01 $ 0.000  Millions$ 0.019  Millions
Cannapharmarx Inc   0.01 $ 0.005  Millions$ 0.849  Millions
Generex Biotechnology Corp  0.01 $ 0.047  Millions$ 8.733  Millions

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com